- Eli Lilly raises forecasts as diabetes drug Mounjaro powers upbeat resultsReuters
- Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85%CNBC
- Eli Lilly Stock Jumps After Results Smashed. Obesity Drugs Delivered the Goods.Barron’s
- Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heightsAOL
- Eli Lilly Stock Price Heads for Record High, Thanks to Weight-Loss Drug MounjaroThe Wall Street Journal
- View Full Coverage on Google News